Holen Sie sich die Stockscreener-App
10.57
0.00%
0.00
Handel nachbörslich:
10.57
Schlusskurs vom Vortag:
$10.57
Offen:
$10.55
24-Stunden-Volumen:
1,768
Relative Volume:
0.03
Marktkapitalisierung:
$209.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.19%
1M Leistung:
+1.05%
6M Leistung:
+4.65%
1J Leistung:
+0.00%
1-Tages-Spanne:
$10.55
$10.57
1-Wochen-Bereich:
$10.50
$10.59
52-Wochen-Spanne:
$9.95
$10.85
Oaktree Acquisition Corp Iii Life Sciences Stock (OACC) Company Profile
Firmenname
Oaktree Acquisition Corp Iii Life Sciences
Sektor
Branche
Telefon
213-830-6300
Adresse
333 SOUTH GRAND AVENUE, 28TH FLOOR, LOS ANGELES
Vergleichen Sie OACC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OACC
Oaktree Acquisition Corp Iii Life Sciences
|
10.57 | 259.84M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
5.97 | 1.77B | 3.13B | -174.20M | -111.20M | -0.6688 |
|
CCCX
Churchill Capital Corp X
|
22.41 | 1.12B | 0 | 0 | 0 | 0.00 |
|
EVAC
Eqv Ventures Acquisition Corp Ii
|
9.975 | 588.46M | 0 | 0 | 0 | 0.00 |
|
AEXA
American Exceptionalism Acquisition Corp A
|
11.31 | 560.88M | 0 | 0 | 0 | 0.00 |
|
AAM
Aa Mission Acquisition Corp
|
10.53 | 463.54M | 0 | 0 | 0 | 0.00 |
Oaktree Acquisition Corp Iii Life Sciences Aktie (OACC) Neueste Nachrichten
Weiss Ratings Reiterates "Sell (D-)" Rating for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) - MarketBeat
Can Oaktree Acquisition Corp. III Life Sciences Equity Warrant hit a new high this month2025 Trading Recap & Intraday High Probability Alerts - newser.com
How Oaktree Acquisition Corp. III Life Sciences stock performs after earnings2025 Volume Leaders & Low Risk High Win Rate Stock Picks - newser.com
What MACD signals say about Oaktree Acquisition Corp. III Life Sciences2025 Trade Ideas & Weekly Setup with ROI Potential - newser.com
Can trapped investors hope for a rebound in Oaktree Acquisition Corp. III Life SciencesMarket Activity Summary & AI Driven Stock Price Forecasts - newser.com
Is Now a Good Time to Buy Suryoday Small Finance Bank Limited Stock Key Indicators ReviewedMoving Average Crossovers & Master Technical Analysis With Free Tools - earlytimes.in
Is Maharashtra Seamless Limited Stock Ready for a Technical BreakoutMid Cap Growth Trends & Affordable Growth Investments - earlytimes.in
How to forecast Oaktree Acquisition Corp. III Life Sciences Equity Warrant trends using time series2025 Investor Takeaways & Weekly Momentum Picks - newser.com
Will New Product Launches Boost Mega Flex Plastics Limiteds Revenue in YEARMarket Timing Techniques & Superior Wealth Growth - earlytimes.in
Full technical analysis of Oaktree Acquisition Corp. III Life Sciences stockMarket Sentiment Report & AI Forecast for Swing Trade Picks - newser.com
Can machine learning forecast Oaktree Acquisition Corp. III Life Sciences recoveryBuy Signal & Weekly Setup with ROI Potential - newser.com
What drives Oruka Therapeutics Inc stock priceMarket Entry Points & Budget Investment Success - earlytimes.in
Institutional scanner results for Oaktree Acquisition Corp. III Life Sciences Equity WarrantWeekly Gains Report & Risk Adjusted Buy/Sell Alerts - newser.com
Is Oaktree Acquisition Corp. III Life Sciences Equity Warrant building a consolidation baseMarket Sentiment Summary & Fast Moving Stock Trade Plans - newser.com
Does Oaktree Acquisition Corp. III Life Sciences qualify in momentum factor screeningJuly 2025 Summary & Community Verified Swing Trade Signals - newser.com
Will Oaktree Acquisition Corp. III Life Sciences stock recover after recent dropJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Is it time to cut losses on Oaktree Acquisition Corp. III Life Sciences Equity WarrantMarket Activity Report & Fast Moving Stock Watchlists - newser.com
Published on: 2025-10-05 04:12:06 - newser.com
Is Advance Metering Technology Limited (534612) a Good Long Term BetGlobal Trade Effects & Budget Friendly Portfolio Growth - earlytimes.in
Why Meson Valves India Limited Might Be One of the Best Stocks in Its IndustryRetail Trading Trends & Low Cost Wealth Building - earlytimes.in
Is Oaktree Acquisition Corp. III Life Sciences Equity Warrant reversing from oversold territoryJuly 2025 Analyst Calls & Growth Focused Investment Plans - newser.com
Multi asset correlation models including Oaktree Acquisition Corp. III Life SciencesQuarterly Portfolio Review & Expert Curated Trade Setup Alerts - newser.com
Is Apollo Hospitals Enterprise Limited Positioned for the Next Major Industry BoomVolume Profile Analysis & Register for the Next Free Workshop - earlytimes.in
Published on: 2025-10-03 05:19:13 - newser.com
Published on: 2025-10-03 04:25:10 - newser.com
What to expect from Oaktree Acquisition Corp. III Life Sciences in the next 30 days2025 Short Interest & Consistent Profit Alerts - newser.com
Why Lion Rock Resources Inc. (KGB) stock attracts HNW investorsJuly 2025 Volume & Comprehensive Market Scan Reports - newser.com
Will AI Trends Push Gautam Exim Limited Stock Even HigherTechnical Analysis Insights & Access Our Free Weekly Investment Letter - earlytimes.in
What drives Oaktree Acquisition Corp III Life Sciences Equity Warrant stock priceGrowth vs. Value Investing & Small Budget Trading Ideas - earlytimes.in
What to Know Before Buying the Dip in Oriental Aromatics LimitedReal Estate Investment Trusts & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in
Real time pattern detection on Oaktree Acquisition Corp. III Life Sciences stockDay Trade & Stepwise Swing Trade Plans - newser.com
OAKM Stock Analysis and ForecastTechnology Stock Trends & Free High Margin Investment Plays - earlytimes.in
Finanzdaten der Oaktree Acquisition Corp Iii Life Sciences-Aktie (OACC)
Es liegen keine Finanzdaten für Oaktree Acquisition Corp Iii Life Sciences (OACC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.50%
12.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):